BD recalled certain intravascular catheters tied to reports of 10 serious injuries after finding an increase in cracks from ...

Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that ...

BD (NYSE: BDX) announced today that it launched a new hemodynamic monitoring platform using predictive AI algorithms.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new advanced ...

Barclays analyst Matt Miksic maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $165.00.

The global peripheral intravenous catheter market is on a strong growth trajectory, projected to more than double in size over the next decade. According to recent market insights, the market is ...